Zevra Therapeutics (ZVRA) Asset Utilization Ratio (2019 - 2026)

Zevra Therapeutics' Asset Utilization Ratio history runs 8 years deep, the most recent figure standing at 0.43 for Q1 2026.

• Quarterly Asset Utilization Ratio rose 88.09% year-over-year to 0.43 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.43 (up 88.09% YoY) and the FY2025 annual result came in at 0.46, up 241.41% from the prior year.
• Asset Utilization Ratio was 0.43 for Q1 2026 at Zevra Therapeutics, up from 0.38 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.43 in Q1 2026 and bottomed at 0.05 in Q4 2022.
• A 5-year average of 0.2 and a median of 0.17 in 2024 frame the typical range for Asset Utilization Ratio.
• Annual changes were most pronounced in 2022 — Asset Utilization Ratio plunged 75.77% — and 2023, when it surged 243.28%.
• Zevra Therapeutics' Asset Utilization Ratio stood at 0.05 in 2022, then jumped by 243.28% to 0.18 in 2023, then retreated by 27.84% to 0.13 in 2024, then soared by 201.58% to 0.38 in 2025, then gained by 13.13% to 0.43 in 2026.
• Business Quant data shows ZVRA's Asset Utilization Ratio at 0.43 in Q1 2026, 0.38 in Q4 2025, and 0.32 in Q3 2025.